Agents that inhibit the progression of chronic kidney disease, and agents that inhibit the progression of proteinuria and / or glomerulosclerosis.
JP7854711B2Active Publication Date: 2026-05-07YAMAGUCHI UNIV
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- YAMAGUCHI UNIV
- Filing Date
- 2022-06-14
- Publication Date
- 2026-05-07
Smart Images

Figure 00000009_0000 
Figure 00000009_0001 
Figure 00000010_0000
Abstract
To provide new agents capable of inhibiting the progression of chronic kidney disease.SOLUTION: A chronic kidney disease progression inhibitor is prepared that includes dantrolene or a pharmaceutically acceptable salt thereof, or a hydrate of them as an active ingredient. Preferably, the inhibitor is applied to chronic kidney disease involving proteinuria and / or glomerulosclerosis and is administered to a patient who has undergone kidney removal or a patient after renal infarction.SELECTED DRAWING: Figure 2
Need to check novelty before this filing date? Find Prior Art